nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Furosemide—dilated cardiomyopathy	0.72	0.896	CbGbCtD
Meloxicam—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0832	0.104	CbGbCtD
Meloxicam—Acute retention of urine—Furosemide—dilated cardiomyopathy	0.0123	0.0684	CcSEcCtD
Meloxicam—CYP2C9—cardial valve—dilated cardiomyopathy	0.00996	0.571	CbGeAlD
Meloxicam—Cytopenia—Lisinopril—dilated cardiomyopathy	0.00715	0.0398	CcSEcCtD
Meloxicam—Low back pain—Lisinopril—dilated cardiomyopathy	0.00667	0.0371	CcSEcCtD
Meloxicam—Bullous eruption—Furosemide—dilated cardiomyopathy	0.00326	0.0182	CcSEcCtD
Meloxicam—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0031	0.0172	CcSEcCtD
Meloxicam—Ulcer—Spironolactone—dilated cardiomyopathy	0.00251	0.0139	CcSEcCtD
Meloxicam—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00243	0.0135	CcSEcCtD
Meloxicam—Bursitis—Lisinopril—dilated cardiomyopathy	0.002	0.0111	CcSEcCtD
Meloxicam—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00195	0.0108	CcSEcCtD
Meloxicam—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00191	0.0106	CcSEcCtD
Meloxicam—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00186	0.0104	CcSEcCtD
Meloxicam—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00179	0.00998	CcSEcCtD
Meloxicam—PGD—myocardium—dilated cardiomyopathy	0.00172	0.0986	CbGeAlD
Meloxicam—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00168	0.00937	CcSEcCtD
Meloxicam—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00157	0.00875	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00155	0.00862	CcSEcCtD
Meloxicam—Gastritis—Spironolactone—dilated cardiomyopathy	0.00152	0.00847	CcSEcCtD
Meloxicam—Drug interaction—Furosemide—dilated cardiomyopathy	0.00139	0.00774	CcSEcCtD
Meloxicam—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00136	0.00754	CcSEcCtD
Meloxicam—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00134	0.00747	CcSEcCtD
Meloxicam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00133	0.00738	CcSEcCtD
Meloxicam—Vasculitis—Furosemide—dilated cardiomyopathy	0.00132	0.00735	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00132	0.00732	CcSEcCtD
Meloxicam—Renal failure—Spironolactone—dilated cardiomyopathy	0.0013	0.00725	CcSEcCtD
Meloxicam—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00124	0.00689	CcSEcCtD
Meloxicam—PGD—heart—dilated cardiomyopathy	0.0012	0.0688	CbGeAlD
Meloxicam—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00115	0.00642	CcSEcCtD
Meloxicam—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00113	0.00626	CcSEcCtD
Meloxicam—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00107	0.00593	CcSEcCtD
Meloxicam—Swelling—Furosemide—dilated cardiomyopathy	0.00106	0.00591	CcSEcCtD
Meloxicam—Alopecia—Spironolactone—dilated cardiomyopathy	0.00105	0.00585	CcSEcCtD
Meloxicam—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00105	0.00582	CcSEcCtD
Meloxicam—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00104	0.0058	CcSEcCtD
Meloxicam—PGD—cardiac atrium—dilated cardiomyopathy	0.00103	0.0589	CbGeAlD
Meloxicam—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00102	0.00566	CcSEcCtD
Meloxicam—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000997	0.00554	CcSEcCtD
Meloxicam—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000993	0.00552	CcSEcCtD
Meloxicam—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000992	0.00552	CcSEcCtD
Meloxicam—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00098	0.00545	CcSEcCtD
Meloxicam—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00098	0.00545	CcSEcCtD
Meloxicam—Purpura—Furosemide—dilated cardiomyopathy	0.000972	0.00541	CcSEcCtD
Meloxicam—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000968	0.00538	CcSEcCtD
Meloxicam—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000962	0.00535	CcSEcCtD
Meloxicam—Wheezing—Lisinopril—dilated cardiomyopathy	0.00094	0.00523	CcSEcCtD
Meloxicam—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00094	0.00523	CcSEcCtD
Meloxicam—Malaise—Spironolactone—dilated cardiomyopathy	0.000935	0.0052	CcSEcCtD
Meloxicam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000928	0.00516	CcSEcCtD
Meloxicam—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000914	0.00508	CcSEcCtD
Meloxicam—Urinary retention—Furosemide—dilated cardiomyopathy	0.000891	0.00495	CcSEcCtD
Meloxicam—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000877	0.00488	CcSEcCtD
Meloxicam—Discomfort—Spironolactone—dilated cardiomyopathy	0.000872	0.00485	CcSEcCtD
Meloxicam—Dehydration—Furosemide—dilated cardiomyopathy	0.000871	0.00484	CcSEcCtD
Meloxicam—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000866	0.00482	CcSEcCtD
Meloxicam—ABCC4—heart—dilated cardiomyopathy	0.000854	0.0489	CbGeAlD
Meloxicam—Confusional state—Spironolactone—dilated cardiomyopathy	0.000853	0.00475	CcSEcCtD
Meloxicam—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000846	0.00471	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000843	0.00469	CcSEcCtD
Meloxicam—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000828	0.00461	CcSEcCtD
Meloxicam—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000804	0.00447	CcSEcCtD
Meloxicam—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0008	0.00445	CcSEcCtD
Meloxicam—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000794	0.00441	CcSEcCtD
Meloxicam—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000782	0.00435	CcSEcCtD
Meloxicam—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000761	0.00423	CcSEcCtD
Meloxicam—Somnolence—Spironolactone—dilated cardiomyopathy	0.000752	0.00418	CcSEcCtD
Meloxicam—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000748	0.00416	CcSEcCtD
Meloxicam—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000739	0.00411	CcSEcCtD
Meloxicam—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000738	0.00411	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000731	0.00406	CcSEcCtD
Meloxicam—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000726	0.00404	CcSEcCtD
Meloxicam—Arthritis—Lisinopril—dilated cardiomyopathy	0.000723	0.00402	CcSEcCtD
Meloxicam—Drowsiness—Furosemide—dilated cardiomyopathy	0.000722	0.00401	CcSEcCtD
Meloxicam—PTGS1—myocardium—dilated cardiomyopathy	0.00072	0.0413	CbGeAlD
Meloxicam—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000716	0.00398	CcSEcCtD
Meloxicam—Renal failure—Furosemide—dilated cardiomyopathy	0.00071	0.00395	CcSEcCtD
Meloxicam—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000703	0.00391	CcSEcCtD
Meloxicam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000697	0.00388	CcSEcCtD
Meloxicam—Sweating—Furosemide—dilated cardiomyopathy	0.000692	0.00385	CcSEcCtD
Meloxicam—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000683	0.0038	CcSEcCtD
Meloxicam—Face oedema—Lisinopril—dilated cardiomyopathy	0.000678	0.00377	CcSEcCtD
Meloxicam—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000674	0.00375	CcSEcCtD
Meloxicam—Urticaria—Spironolactone—dilated cardiomyopathy	0.000672	0.00374	CcSEcCtD
Meloxicam—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000669	0.00372	CcSEcCtD
Meloxicam—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000658	0.00366	CcSEcCtD
Meloxicam—Dehydration—Lisinopril—dilated cardiomyopathy	0.000654	0.00364	CcSEcCtD
Meloxicam—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00064	0.00356	CcSEcCtD
Meloxicam—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000635	0.00353	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000633	0.00352	CcSEcCtD
Meloxicam—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000628	0.0035	CcSEcCtD
Meloxicam—Visual impairment—Furosemide—dilated cardiomyopathy	0.000624	0.00347	CcSEcCtD
Meloxicam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000623	0.00347	CcSEcCtD
Meloxicam—Gastritis—Lisinopril—dilated cardiomyopathy	0.000622	0.00346	CcSEcCtD
Meloxicam—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000613	0.00341	CcSEcCtD
Meloxicam—Influenza—Lisinopril—dilated cardiomyopathy	0.000607	0.00338	CcSEcCtD
Meloxicam—Asthma—Lisinopril—dilated cardiomyopathy	0.000607	0.00338	CcSEcCtD
Meloxicam—Eye disorder—Furosemide—dilated cardiomyopathy	0.000606	0.00337	CcSEcCtD
Meloxicam—Tinnitus—Furosemide—dilated cardiomyopathy	0.000604	0.00336	CcSEcCtD
Meloxicam—Pruritus—Spironolactone—dilated cardiomyopathy	0.000599	0.00333	CcSEcCtD
Meloxicam—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000597	0.00332	CcSEcCtD
Meloxicam—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000596	0.00331	CcSEcCtD
Meloxicam—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000592	0.00329	CcSEcCtD
Meloxicam—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000592	0.00329	CcSEcCtD
Meloxicam—Angiopathy—Furosemide—dilated cardiomyopathy	0.000588	0.00327	CcSEcCtD
Meloxicam—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000585	0.00326	CcSEcCtD
Meloxicam—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000584	0.00325	CcSEcCtD
Meloxicam—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000579	0.00322	CcSEcCtD
Meloxicam—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000579	0.00322	CcSEcCtD
Meloxicam—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000577	0.00321	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000565	0.00314	CcSEcCtD
Meloxicam—Malnutrition—Furosemide—dilated cardiomyopathy	0.000564	0.00314	CcSEcCtD
Meloxicam—Erythema—Furosemide—dilated cardiomyopathy	0.000564	0.00314	CcSEcCtD
Meloxicam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00056	0.00311	CcSEcCtD
Meloxicam—Flatulence—Furosemide—dilated cardiomyopathy	0.000556	0.00309	CcSEcCtD
Meloxicam—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000554	0.00308	CcSEcCtD
Meloxicam—Weight increased—Lisinopril—dilated cardiomyopathy	0.000553	0.00307	CcSEcCtD
Meloxicam—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000552	0.00307	CcSEcCtD
Meloxicam—CYP2C9—heart—dilated cardiomyopathy	0.000551	0.0316	CbGeAlD
Meloxicam—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00055	0.00306	CcSEcCtD
Meloxicam—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000542	0.00302	CcSEcCtD
Meloxicam—Vomiting—Spironolactone—dilated cardiomyopathy	0.000538	0.00299	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000537	0.00299	CcSEcCtD
Meloxicam—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000534	0.00297	CcSEcCtD
Meloxicam—Rash—Spironolactone—dilated cardiomyopathy	0.000534	0.00297	CcSEcCtD
Meloxicam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000533	0.00296	CcSEcCtD
Meloxicam—Renal failure—Lisinopril—dilated cardiomyopathy	0.000532	0.00296	CcSEcCtD
Meloxicam—Vision blurred—Furosemide—dilated cardiomyopathy	0.000532	0.00296	CcSEcCtD
Meloxicam—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000531	0.00295	CcSEcCtD
Meloxicam—Headache—Spironolactone—dilated cardiomyopathy	0.00053	0.00295	CcSEcCtD
Meloxicam—Jaundice—Lisinopril—dilated cardiomyopathy	0.000528	0.00294	CcSEcCtD
Meloxicam—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000526	0.00293	CcSEcCtD
Meloxicam—Anaemia—Furosemide—dilated cardiomyopathy	0.000521	0.0029	CcSEcCtD
Meloxicam—Sweating—Lisinopril—dilated cardiomyopathy	0.000519	0.00289	CcSEcCtD
Meloxicam—Haematuria—Lisinopril—dilated cardiomyopathy	0.000516	0.00287	CcSEcCtD
Meloxicam—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000512	0.00285	CcSEcCtD
Meloxicam—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000508	0.00283	CcSEcCtD
Meloxicam—Vertigo—Furosemide—dilated cardiomyopathy	0.000507	0.00282	CcSEcCtD
Meloxicam—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000505	0.00281	CcSEcCtD
Meloxicam—Leukopenia—Furosemide—dilated cardiomyopathy	0.000505	0.00281	CcSEcCtD
Meloxicam—Nausea—Spironolactone—dilated cardiomyopathy	0.000503	0.0028	CcSEcCtD
Meloxicam—PTGS1—heart—dilated cardiomyopathy	0.000503	0.0288	CbGeAlD
Meloxicam—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000487	0.00271	CcSEcCtD
Meloxicam—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000486	0.0027	CcSEcCtD
Meloxicam—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000483	0.00268	CcSEcCtD
Meloxicam—PTGS2—heart—dilated cardiomyopathy	0.00048	0.0275	CbGeAlD
Meloxicam—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00048	0.00267	CcSEcCtD
Meloxicam—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000479	0.00266	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000477	0.00265	CcSEcCtD
Meloxicam—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000477	0.00265	CcSEcCtD
Meloxicam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00047	0.00261	CcSEcCtD
Meloxicam—Confusional state—Furosemide—dilated cardiomyopathy	0.000464	0.00258	CcSEcCtD
Meloxicam—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00046	0.00256	CcSEcCtD
Meloxicam—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00046	0.00256	CcSEcCtD
Meloxicam—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000453	0.00252	CcSEcCtD
Meloxicam—Shock—Furosemide—dilated cardiomyopathy	0.000453	0.00252	CcSEcCtD
Meloxicam—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000451	0.00251	CcSEcCtD
Meloxicam—Flushing—Lisinopril—dilated cardiomyopathy	0.000451	0.00251	CcSEcCtD
Meloxicam—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000451	0.00251	CcSEcCtD
Meloxicam—Skin disorder—Furosemide—dilated cardiomyopathy	0.000447	0.00249	CcSEcCtD
Meloxicam—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000445	0.00248	CcSEcCtD
Meloxicam—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000441	0.00245	CcSEcCtD
Meloxicam—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000438	0.00244	CcSEcCtD
Meloxicam—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000434	0.00242	CcSEcCtD
Meloxicam—Hypotension—Furosemide—dilated cardiomyopathy	0.00043	0.00239	CcSEcCtD
Meloxicam—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00043	0.0246	CbGeAlD
Meloxicam—Alopecia—Lisinopril—dilated cardiomyopathy	0.00043	0.00239	CcSEcCtD
Meloxicam—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000426	0.00237	CcSEcCtD
Meloxicam—Erythema—Lisinopril—dilated cardiomyopathy	0.000423	0.00235	CcSEcCtD
Meloxicam—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000423	0.00235	CcSEcCtD
Meloxicam—Flatulence—Lisinopril—dilated cardiomyopathy	0.000417	0.00232	CcSEcCtD
Meloxicam—Tension—Lisinopril—dilated cardiomyopathy	0.000415	0.00231	CcSEcCtD
Meloxicam—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000414	0.00231	CcSEcCtD
Meloxicam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000413	0.0023	CcSEcCtD
Meloxicam—Nervousness—Lisinopril—dilated cardiomyopathy	0.000411	0.00229	CcSEcCtD
Meloxicam—Back pain—Lisinopril—dilated cardiomyopathy	0.000409	0.00228	CcSEcCtD
Meloxicam—Somnolence—Furosemide—dilated cardiomyopathy	0.000409	0.00228	CcSEcCtD
Meloxicam—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000407	0.00226	CcSEcCtD
Meloxicam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0004	0.00223	CcSEcCtD
Meloxicam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000399	0.00222	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000397	0.00221	CcSEcCtD
Meloxicam—Fatigue—Furosemide—dilated cardiomyopathy	0.000397	0.00221	CcSEcCtD
Meloxicam—Tremor—Lisinopril—dilated cardiomyopathy	0.000397	0.00221	CcSEcCtD
Meloxicam—Constipation—Furosemide—dilated cardiomyopathy	0.000394	0.00219	CcSEcCtD
Meloxicam—Pain—Furosemide—dilated cardiomyopathy	0.000394	0.00219	CcSEcCtD
Meloxicam—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000393	0.00218	CcSEcCtD
Meloxicam—Anaemia—Lisinopril—dilated cardiomyopathy	0.000391	0.00218	CcSEcCtD
Meloxicam—Angioedema—Lisinopril—dilated cardiomyopathy	0.000387	0.00215	CcSEcCtD
Meloxicam—Malaise—Lisinopril—dilated cardiomyopathy	0.000382	0.00212	CcSEcCtD
Meloxicam—Vertigo—Lisinopril—dilated cardiomyopathy	0.00038	0.00211	CcSEcCtD
Meloxicam—Syncope—Lisinopril—dilated cardiomyopathy	0.00038	0.00211	CcSEcCtD
Meloxicam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000379	0.00211	CcSEcCtD
Meloxicam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000379	0.00211	CcSEcCtD
Meloxicam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000376	0.00209	CcSEcCtD
Meloxicam—Palpitations—Lisinopril—dilated cardiomyopathy	0.000374	0.00208	CcSEcCtD
Meloxicam—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000372	0.00207	CcSEcCtD
Meloxicam—Cough—Lisinopril—dilated cardiomyopathy	0.000369	0.00205	CcSEcCtD
Meloxicam—Urticaria—Furosemide—dilated cardiomyopathy	0.000366	0.00203	CcSEcCtD
Meloxicam—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000364	0.00202	CcSEcCtD
Meloxicam—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000364	0.00202	CcSEcCtD
Meloxicam—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00036	0.002	CcSEcCtD
Meloxicam—Myalgia—Lisinopril—dilated cardiomyopathy	0.00036	0.002	CcSEcCtD
Meloxicam—Anxiety—Lisinopril—dilated cardiomyopathy	0.000359	0.002	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000358	0.00199	CcSEcCtD
Meloxicam—Discomfort—Lisinopril—dilated cardiomyopathy	0.000356	0.00198	CcSEcCtD
Meloxicam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000352	0.00196	CcSEcCtD
Meloxicam—Confusional state—Lisinopril—dilated cardiomyopathy	0.000348	0.00194	CcSEcCtD
Meloxicam—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000345	0.00192	CcSEcCtD
Meloxicam—Oedema—Lisinopril—dilated cardiomyopathy	0.000345	0.00192	CcSEcCtD
Meloxicam—Infection—Lisinopril—dilated cardiomyopathy	0.000343	0.00191	CcSEcCtD
Meloxicam—Shock—Lisinopril—dilated cardiomyopathy	0.00034	0.00189	CcSEcCtD
Meloxicam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000339	0.00189	CcSEcCtD
Meloxicam—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000338	0.00188	CcSEcCtD
Meloxicam—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000337	0.00188	CcSEcCtD
Meloxicam—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000336	0.00187	CcSEcCtD
Meloxicam—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000334	0.00186	CcSEcCtD
Meloxicam—Asthenia—Furosemide—dilated cardiomyopathy	0.00033	0.00184	CcSEcCtD
Meloxicam—Pruritus—Furosemide—dilated cardiomyopathy	0.000326	0.00181	CcSEcCtD
Meloxicam—Hypotension—Lisinopril—dilated cardiomyopathy	0.000323	0.0018	CcSEcCtD
Meloxicam—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000315	0.00175	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000315	0.00175	CcSEcCtD
Meloxicam—Insomnia—Lisinopril—dilated cardiomyopathy	0.000312	0.00174	CcSEcCtD
Meloxicam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00031	0.00173	CcSEcCtD
Meloxicam—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000308	0.00171	CcSEcCtD
Meloxicam—Somnolence—Lisinopril—dilated cardiomyopathy	0.000307	0.00171	CcSEcCtD
Meloxicam—Dizziness—Furosemide—dilated cardiomyopathy	0.000304	0.00169	CcSEcCtD
Meloxicam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000304	0.00169	CcSEcCtD
Meloxicam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0003	0.00167	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000298	0.00166	CcSEcCtD
Meloxicam—Fatigue—Lisinopril—dilated cardiomyopathy	0.000298	0.00166	CcSEcCtD
Meloxicam—Pain—Lisinopril—dilated cardiomyopathy	0.000295	0.00164	CcSEcCtD
Meloxicam—Constipation—Lisinopril—dilated cardiomyopathy	0.000295	0.00164	CcSEcCtD
Meloxicam—Vomiting—Furosemide—dilated cardiomyopathy	0.000293	0.00163	CcSEcCtD
Meloxicam—Rash—Furosemide—dilated cardiomyopathy	0.00029	0.00161	CcSEcCtD
Meloxicam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00029	0.00161	CcSEcCtD
Meloxicam—Headache—Furosemide—dilated cardiomyopathy	0.000288	0.0016	CcSEcCtD
Meloxicam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000285	0.00158	CcSEcCtD
Meloxicam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000282	0.00157	CcSEcCtD
Meloxicam—Urticaria—Lisinopril—dilated cardiomyopathy	0.000274	0.00153	CcSEcCtD
Meloxicam—Nausea—Furosemide—dilated cardiomyopathy	0.000273	0.00152	CcSEcCtD
Meloxicam—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000273	0.00152	CcSEcCtD
Meloxicam—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000273	0.00152	CcSEcCtD
Meloxicam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000254	0.00142	CcSEcCtD
Meloxicam—Asthenia—Lisinopril—dilated cardiomyopathy	0.000248	0.00138	CcSEcCtD
Meloxicam—Pruritus—Lisinopril—dilated cardiomyopathy	0.000244	0.00136	CcSEcCtD
Meloxicam—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000236	0.00131	CcSEcCtD
Meloxicam—Dizziness—Lisinopril—dilated cardiomyopathy	0.000228	0.00127	CcSEcCtD
Meloxicam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00022	0.00122	CcSEcCtD
Meloxicam—Rash—Lisinopril—dilated cardiomyopathy	0.000218	0.00121	CcSEcCtD
Meloxicam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000218	0.00121	CcSEcCtD
Meloxicam—Headache—Lisinopril—dilated cardiomyopathy	0.000216	0.0012	CcSEcCtD
Meloxicam—Nausea—Lisinopril—dilated cardiomyopathy	0.000205	0.00114	CcSEcCtD
